Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
JCO Clinical Cancer Informatics|November 13, 2025
Acute Care Utilization Patterns During Chemotherapy and Predictive Model Development at a Rural Community Cancer CenterMcKenna Perrin, Crystal Hattum, Jamie Arens, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|June 23, 2025
Analysis of Response to Pembrolizumab and Lenvatinib in pMMR Endometrial Cancers: A Retrospective Cohort StudyLinze Christensen, Crystal Hattum, Tobias Meissner, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|June 23, 2025
A Retrospective Study of Social Determinants of Health Effects on Clinical Trial ConsiderationLogan Stacey, Bing Xu, Crystal Hattum, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|July 29, 2026
Evaluation of Factors Affecting Clinical Trial Consideration and Enrollment for Cancer PatientsLogan Stacey, Bing Xu, Crystal Hattum, et al.
Inhalation Toxicology|June 30, 2009
Physico-chemical characterization in the light of toxicological effectsTobias Meissner, Annegret Potthoff, Volkmar Richter
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|January 16, 2016
A Furan-Based Lewis-Y-(CD174)-Saccharide Mimetic Inhibits Endothelial Functions and In Vitro AngiogenesisSandra Sauer, Tobias Meissner, Thomas Moehler
Oncotarget|July 21, 2026
WIN-MTB-2024017 - WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancersWafik S El-Deiry, Alberto Hernando-Calvo, Don Dizon, et al.
JCO Oncology Practice|April 15, 2024
Genomic Considerations in the Treatment of Thyroid CarcinomaCrystal J Hattum, Rachel J Elsey, Tobias Meissner, et al.
Nanotoxicology|August 28, 2010
Physical-chemical characterization of tungsten carbide nanoparticles as a basis for toxicological investigationsTobias Meissner, Dana Kühnel, Wibke Busch, et al.
Pageof 4